Galectin Therapeutics
GALT
#8398
Rank
โ‚ฌ0.17 B
Marketcap
2,73ย โ‚ฌ
Share price
-1.11%
Change (1 day)
73.58%
Change (1 year)

Earnings for Galectin Therapeutics (GALT)

Earnings in 2025 (TTM): -โ‚ฌ33.76 Million

According to Galectin Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚ฌ41.05 Million a decrease over its 2023 earnings that were of -โ‚ฌ35.84 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Galectin Therapeutics from 2002 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ33.76 Million-17.77%
2024 -โ‚ฌ41.05 Million14.56%
2023 -โ‚ฌ35.84 Million5.91%
2022 -โ‚ฌ33.84 Million27.02%
2021 -โ‚ฌ26.64 Million30.1%
2020 -โ‚ฌ20.48 Million76.51%
2019 -โ‚ฌ11.6 Million-4.36%
2018 -โ‚ฌ12.13 Million-14.38%
2017 -โ‚ฌ14.17 Million-24.26%
2016 -โ‚ฌ18.71 Million7.04%
2015 -โ‚ฌ17.48 Million26.85%
2014 -โ‚ฌ13.78 Million30.61%
2013 -โ‚ฌ10.55 Million27.82%
2012 -โ‚ฌ8.26 Million-9.15%
2011 -โ‚ฌ9.09 Million113.17%
2010 -โ‚ฌ4.27 Million-19.86%
2009 -โ‚ฌ5.32 Million14.4%
2008 -โ‚ฌ4.65 Million-17.49%
2007 -โ‚ฌ5.64 Million-8.41%
2006 -โ‚ฌ6.15 Million5.91%
2005 -โ‚ฌ5.81 Million-8.89%
2004 -โ‚ฌ6.38 Million47.92%
2003 -โ‚ฌ4.31 Million50.22%
2002 -โ‚ฌ2.87 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Mirati Therapeutics
MRTX
-โ‚ฌ0.67 Billion 1,950.42%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
โ‚ฌ26.85 M-182.52%๐Ÿ‡บ๐Ÿ‡ธ USA